Ardelyx Inc

Stock Chart, Company Information, and Scan Results

$6.88(as of May 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ardelyx Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$6.88
Ticker SymbolARDX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees489
CountyUSA
Market Cap$1,699.6M
EBIDTA-34.0M
10-Day Moving Average6.14
P/E Ratio-29.13
20-Day Moving Average6.17
Forward P/E Ratio38.17
50-Day Moving Average6.04
Earnings per Share-0.24
200-Day Moving Average5.97
Profit Margin-39.81%
RSI69.58
Shares Outstanding247.0M
ATR0.32
52-Week High8.40
Volume11,622,800
52-Week Low3.21
Most Recent Support Level5.82
Book Value148.6M
Most Recent Resistance Level6.16
P/B Ratio11.38
Upper Keltner6.90
P/S Ratio3.96
Lower Keltner5.44
Debt-to-Equity Ratio6.90
Next Earnings DateUnknown
Cash Surplus-78.4M
Next Ex-Dividend DateUnknown

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ardelyx Inc In Our Stock Scanner

As of May 04, 2026
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.